BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer
Clinical trial NCT00098254 · COMPLETED
Trial details
- NCT number
- NCT00098254
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2009-11-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.